![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-desktop-w27gif-57924.gif)
![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-mobile-w27gif-62411.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.reuters.com/business/healthcare-pharmaceuticals/nestle-launches-website-individuals-weight-loss-drugs-2024-06-25/
https://www.globenewswire.com/news-release/2024/06/06/2894527/0/en/Seres-Therapeutics-Enters-Into-Memorandum-of-Understanding-For-Vowst-Asset-Sale-to-Nestl%C3%A9-Health-Science.html
https://www.prnewswire.com/news-releases/nestle-health-science-agrees-to-acquire-global-rights-to-vowst-product-it-launched-in-june-2023-302165294.html
https://www.fiercebiotech.com/biotech/sanofi-cso-frank-nestle-leaving
https://www.reuters.com/business/healthcare-pharmaceuticals/sanofi-q1-profit-slips-generic-competition-forex-effects-2024-04-25/
https://www.reuters.com/business/retail-consumer/nestle-india-subsidiary-beats-profit-estimates-higher-demand-2024-04-25/
https://endpts.com/nestle-health-science-plots-next-steps-for-c-diff-drug-vowst-after-robust-uptake/
https://endpts.com/nestle-reconsiders-peanut-allergy-program-two-years-after-2-6b-buyout/